GENOMICS


Pre-eXams), which compares traditional practice with predictive pre-eXams to action the plan, and Table 8 (Real-world AI for Clinical Practice Digital Twin eXams), which illustrates HPO biopharma ‘eXam’ intercepts like gene-protein (with functional genomics) bio targets and drug optimisation. Furthermore, the blueprint addresses the critical challenge of data integration and utilisation at scale. The true power of genomic medicine and the HPO (primarily of genomic origin) lies in synergistic analysis of data points. The detailed consideration of federated learning4


is paramount here, as it


uniquely increases analytical capacity over vast, decentralised HPO data with secondary origins, allowing for secure, collaborative insights across diverse institutions without centralising sensitive patient information. This directly increases analytical capability by enabling larger-scale model training and discovery. Its implementation is critical, supported by the AI Digital Regulation Service (AIDRS),14


which


ensures compliant and ethical data sharing and HPO development for adoption across this ecosystem. Table 5 (Metrics for Precise Care eXams from Pre-eXams) presents AI tools and applications in digital genomic analysis for personalised medicine, directly supporting these technical underpinnings. The secure data integrity maintained during large- scale AI deployment, as illustrated by Figure 2, is critical for building public confidence, and the foundational terms and concepts for this transformation are clarified in Table 2 (HIMSS development of HPO transformation and HEMSS PHM adoption). The discussion on quantum computing5


highlights


its potential for unprecedented computational capacity to identify ultra- complex, multi-factorial HPO patterns and genomic correlations currently intractable for classical computers, thereby significantly increasing research capability. This capability is vital for accelerating the discovery of subtle disease pathways and personalised treatment strategies for data of primarily genomic origin. Its integration relies on the AI Research Resource (AIRR)15 providing the advanced infrastructure for such transformative computational research. Similarly, generative AI6


is


crucial for increasing data capacity and research capability by simulating novel HPO profiles or generating large, synthetic datasets from genomic data, accelerating model training and discovery, all while the AI Security Institute (AISI)16


ensures the integrity


and safety of both generated data and AI models.


The vision extends beyond technological deployment to crucial elements of standardisation and ethical governance. Without robust ISO compliance, as detailed in Table 9 (International Key Expert Areas Guidance on HPO Transformation) which highlights guidance on HPO transformation with standard interoperable access, and a strong ethical stewardship model like HEMSS, even the most advanced HIMSS technological solutions will fall short in broad-scale implementation. The manuscript proactively addresses challenges like algorithmic bias and data inequalities, offering concrete mitigation strategies, whose effectiveness can be measured using metrics presented in Table 6 (AI-HPO Bias Mitigation Metrics), which focuses on metrics and strategies to reduce bias in HPO. This comprehensive approach aims to build unwavering public trust, ensuring the benefits of this advanced health ecosystem are accessible and equitable for all, aligning perfectly with the plan’s commitment to reducing health disparities, a concept further reinforced by Figure 5. The economic implications of this plan


are also significant. By focusing on value- based care classifications and utilising AI for efficiency, a substantial return on investment is anticipated through reduced healthcare costs. The detailed Table 10 (HPO Transformation Roadmap) provides a clear, phased implementation strategy, allowing careful resource allocation and measurable progress, directly supporting the long-term financial sustainability the 10-Year Health Plan seeks to achieve. The operational efficiency driven into practice through data science and AI technology, impacting biological modelling for value- based care, is depicted in Figure 4, with the overall ecosystem value and impact of HPO transformation demonstrated in Table 3 (System thinking: Ecosystem Value and Impact for HPO Transformation). The ability to measure the effectiveness of AI-driven interventions for efficiency and outcomes is supported by Table 4 (AI- HPO Intercept Metrics), which provides detailed calculations for monitoring


progress against the plan. In essence, HPO, primarily of genomic origin, is not simply a biological model but a linchpin for ecosystemic healthcare reform. It’s the structured language allowing diverse data types to communicate, with the standardised interface for AI applications, and the foundational element for genuinely personalised care pathways. It’s firmly believed that adopting and developing this outlined infrastructure will empower the UK to leapfrog existing limitations and create a truly ‘fit for the future’ health system, one that is proactive, precise, efficient, and deeply trusted by its citizens. The achievement of the 10-Year Plan hinges on adopting such an ecosystem with an integrated data strategy.


Limitations and challenges While the proposed HPO infrastructure offers a robust blueprint, several limitations and challenges must be addressed during implementation. Their management is often implicitly addressed by the structured approach detailed in the tables: n Significant initial investment: Transitioning to a comprehensive HPO- driven system, including technological upgrades and training, requires substantial financial investment and political will, achievable within a decade of reform. The phased approach outlined in Table 10 (HPO Transformation Roadmap) is crucial for managing this investment over time, breaking it down into manageable stages with defined outcomes and metrics.1-3


n Data interoperability hurdles: Despite standardisation efforts,21-25


integrating


legacy IT systems and disparate data sources across the NHS presents complex technical and organisational challenges. Overcoming these is achievable with HEMSS stewardship of HIMSS,26


leveraging the international


guidance on HPO transformation with standard interoperable access found in Table 9 (International Key Expert Areas Guidance on HPO Transformation).


n Workforce training and adaptation: Successful transformation necessitates


HPO is the structured language allowing diverse data types to communicate, and the standardised interface for AI applications, and the foundational element for genuinely personalised care pathways


WWW.PATHOLOGYINPRACTICE.COM AUGUST 2025 57


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72